Product analysis
CoQ10-Plus combines CoQ10 with plant extracts and fish-oil fats for possible support of heart-related functions. The small amounts of several added ingredients and unclear preparations limit what the broader mix can be expected to contribute.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Most preparations are not identified clearly enough to compare ingredient quality. The mixed ingredient description also leaves uncertainty about the full composition.
Ingredient Transparency66
Many amounts are stated, but some ingredients are grouped in a mixed description without a clear individual breakdown. Most precise forms are missing, although some component proportions are disclosed.
Value For Money29
The cost looks high for the amounts of CoQ10, EPA and DHA supplied. Value from several other ingredients remains uncertain, so the broad mix does not establish an economical purchase.
Customer Satisfaction74
Customer ratings are very favorable. The modest feedback volume gives a limited view of satisfaction without proving heart or cognitive benefits.
Product Focus41
The clearest possible contribution concerns selected heart-related markers from CoQ10. The many wider aims around energy, attention and brain health have mixed support or rely on small ingredient amounts.
- Format
Softgel - Container
- 60 Liquid(s)
- Per serving
- $0.87
- Customer rating
- 4.8 · 133 ratings
Goals
CoQ10 supports mitochondrial processes and has limited preparation-specific evidence for fatigue. The 100 mg declaration lacks a specified redox form, so its match to researched ubiquinone or ubiquinol remains uncertain.
Vitamin D findings concern deficient adults rather than reliable routine energy improvement. Fish oil adds no established fatigue benefit simply from its 700 mg total mass.
How this product is rated for Energy
Ingredient fit39
Goal fit
Dose adequacy
Pathways8
Depth
Breadth
Evidence86
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
CoQ10-Plus lists 100 mg CoQ10, 200 mg hawthorn extract, and 126 mg EPA per serving, with the clearest route through endothelial nitric-oxide function. DHA and resveratrol are below the amounts counted here, and many other actives are outside this goal. Marker support does not establish event prevention.
How this product is rated for Cardiovascular Support
Ingredient fit48
Goal fit
Dose adequacy
Pathways53
Depth
Breadth
Evidence88
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Coenzyme Q10 has limited evidence for vascular, blood-pressure and lipid markers in small, selected populations. Its declared active amount provides the main relevant contribution here, without establishing a superior delivery form or fewer cardiovascular events. Hawthorn's specific clinical extract findings do not establish the same effects for this preparation.
How this product is rated for Heart Health
Ingredient fit50
Goal fit
Dose adequacy
Pathways57
Depth
Breadth
Evidence98
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
Ginkgo at 120 mg has mixed findings for attention and concentration. DHA and EPA evidence concerns repeated intake rather than immediate focus, while vitamin D's nutritional role does not establish sharper attention when needs are met.
How this product is rated for Mental Focus
Ingredient fit49
Goal fit
Dose adequacy
Pathways44
Depth
Breadth
Evidence69
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
DHA contributes to normal brain function and supplies part of nerve-cell structure. The declared 84 mg is a modest nutritional contribution and is too low to count in the saved findings. Ginkgo has not reliably slowed cognitive decline, while the small resveratrol amount and vitamin D provide no established broad cognitive enhancement.
How this product is rated for Brain Health
Ingredient fit49
Goal fit
Dose adequacy
Pathways43
Depth
Breadth
Evidence80
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Total Fat | 1 Gram(s) | |
Cholesterol | 5 mg | |
Total Carbohydrates | 1 Gram(s) | |
Protein | 1 Gram(s) | |
Vitamin D3 (Cholecalciferol) | 25 mcg | |
Fish Oil (Anchovy, Sardine) | 700 mg | |
Eicosapentaenoic Acid | 126 mg | |
Docosahexaenoic Acid | 84 mg | |
Hawthorn Berry Extract (Crataegus oxyacantha Berry Extract) | 200 mg | |
Ginkgo leaf extract | 120 mg | |
Chia Seed Oil | 100 mg | |
Coenzyme Q-10 | 100 mg | |
Cayenne, Powder | 60 mg | |
Gotu Kola Whole Herb Extract | 60 mg | |
Triterpenes | 6 mg | |
Citrus (Citrus spp.) fruit extract | 50 mg | |
Bioflavonoids | 25 mg | |
Hibiscus Flower Extract (Hibiscus sabdariffa Flower Extract) | 50 mg | |
Resveratrol (Japanese Knotweed root extract) | 10 mg | |
BioPerine Complex | 6 mg | |
BioPerine (Black Pepper Fruit Extract) | 0 NP | |
Ginger Rhizome Extract (Gingerols) | 0 NP |
How this ingredient is rated
Active Ingredient Quality & Bioavailability28
Molecular Form: Ubiquinol vs. Ubiquinone
Formulation & Absorption Enhancers
Dose, Safety & Label Transparency42
Clinical Dosage Alignment
Label Transparency & Fillers
Value20
Price Per Effective Serving
How this ingredient is rated
Active Ingredient Quality & Bioavailability35
Standardization and Active Marker Disclosure
Bioavailability and Delivery Technology
Dose, Safety & Label Transparency82
Declared Flavonoid Ingredient Amount
Label Transparency and Blend Clarity
Value30
Price per 100mg Declared Flavonoid Ingredient
How this ingredient is rated
Composition and Label Disclosure0
Marker and Preparation Disclosure
Declared Ginkgolic Acid Limit
Composition and Label Disclosure100
Individual Preparation Amount Disclosure
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Vitamin D and brain health: an observational and Mendelian randomization study.
- The association between vitamin D and cognition: a systematic review.
- Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults.
- Vitamin D insufficiency and cognitive impairment in Asians: a multi-ethnic population-based study and meta-analysis.
- Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.